PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 31, Issue 4, Pages 1756-1766
Publisher
FASEB
Online
2017-01-18
DOI
10.1096/fj.201601147r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guillain-Barré syndrome
- (2016) Hugh J Willison et al. LANCET
- Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?
- (2015) Xiujuan Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
- (2015) Hiroaki Kimura et al. Journal of Immunology Research
- Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
- (2014) Anbalagan Jaganathan et al. MOLECULAR ENDOCRINOLOGY
- Mitigated Tregs and Augmented Th17 Cells and Cytokines are Associated with Severity of Experimental Autoimmune Neuritis
- (2014) X. Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Assembly of the 20S proteasome
- (2013) Mary J. Kunjappu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Th1/Th2/Th17/Treg cytokines in Guillain–Barré syndrome and experimental autoimmune neuritis
- (2013) Hong-Liang Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Glatiramer acetate ameliorates experimental autoimmune neuritis
- (2013) Cun-Jin Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)
- (2013) Pieter A. van Doorn PRESSE MEDICALE
- Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity
- (2012) Eva M. Huber et al. CELL
- Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice
- (2012) Y. Nagayama et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The immunoproteasome in antigen processing and other immunological functions
- (2012) Michael Basler et al. CURRENT OPINION IN IMMUNOLOGY
- Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain–Barré syndrome
- (2012) Song-lan Liang et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Immunoproteasome Subunit LMP7 Deficiency and Inhibition Suppresses Th1 and Th17 but Enhances Regulatory T Cell Differentiation
- (2012) K. W. Kalim et al. JOURNAL OF IMMUNOLOGY
- How does adaptation sweep through the genome? Insights from long-term selection experiments
- (2012) M. K. Burke PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice
- (2010) Jacqueline Moebius et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
- (2010) M. Basler et al. JOURNAL OF IMMUNOLOGY
- The role of cytokines in Guillain–Barré syndrome
- (2010) Ming-Ou Lu et al. JOURNAL OF NEUROLOGY
- A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
- (2009) Tony Muchamuel et al. NATURE MEDICINE
- FTY720 attenuates lesional interleukin-17+cell accumulation in rat experimental autoimmune neuritis
- (2009) Z-Y. Zhang et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- Bortezomib in the front-line treatment of multiple myeloma
- (2008) Paul G Richardson et al. Expert Review of Anticancer Therapy
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started